Multi-national health sciences company Sami-Sabinsa announced that Dr. Muhammed Majeed’s children will carry on their father’s legacy at the helm of the business he founded 36 years ago. Dr. Majeed died March 13 at age 75 following complications from...
Pharmaceutical corporation Sabinsa completed a 90 day, multicentric randomised open label trial of its Amla, aka Indian gooseberry, extract and concluded it could provide blood sugar benefits.
The supplementation of a formula containing seven herbal extracts has shown effects comparable to the blood sugar control drug metformin in prediabetic and newly diagnosed diabetic patients, according to a RCT by Sabinsa.
A combination of Sabinsa’s curcumin and piperine (black pepper extract) showed faster symptomatic recovery among COVID-19 patients in India, according to findings from a recent clinical trial.